vs
Side-by-side financial comparison of PLUS THERAPEUTICS, INC. (PSTV) and Rigetti Computing, Inc. (RGTI). Click either name above to swap in a different company.
Rigetti Computing, Inc. is the larger business by last-quarter revenue ($1.9M vs $1.4M, roughly 1.4× PLUS THERAPEUTICS, INC.). PLUS THERAPEUTICS, INC. runs the higher net margin — -417.9% vs -974.7%, a 556.8% gap on every dollar of revenue. On growth, PLUS THERAPEUTICS, INC. posted the faster year-over-year revenue change (-3.2% vs -17.9%). PLUS THERAPEUTICS, INC. produced more free cash flow last quarter ($-6.3M vs $-19.5M). Over the past eight quarters, PLUS THERAPEUTICS, INC.'s revenue compounded faster (-9.7% CAGR vs -21.8%).
Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company headquartered in Houston, Texas, that develops targeted radiotherapeutics and diagnostic services for brain and central nervous system (CNS) cancers. The company’s lead therapeutic candidate, marketed as REYOBIQ™, is an investigational liposomal radiopharmaceutical under clinical evaluation for recurrent glioblastoma, leptomeningeal metastases, and certain pediatric brain cancers. Plus Therapeutics also commercialized a molecu...
Rigetti Computing, Inc. is a Berkeley, California-based developer of superconducting quantum integrated circuits used for quantum computers. Rigetti also develops a cloud platform called Forest that enables programmers to write quantum algorithms.
PSTV vs RGTI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.4M | $1.9M |
| Net Profit | $-5.7M | $-18.2M |
| Gross Margin | — | 34.9% |
| Operating Margin | -420.0% | -1209.7% |
| Net Margin | -417.9% | -974.7% |
| Revenue YoY | -3.2% | -17.9% |
| Net Profit YoY | -46.4% | 88.1% |
| EPS (diluted) | $0.95 | $-0.08 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.4M | $1.9M | ||
| Q3 25 | $1.4M | $1.9M | ||
| Q2 25 | $1.4M | $1.8M | ||
| Q1 25 | $1.1M | $1.5M | ||
| Q4 24 | $1.4M | $2.3M | ||
| Q3 24 | $1.5M | $2.4M | ||
| Q2 24 | $1.3M | $3.1M | ||
| Q1 24 | $1.7M | $3.1M |
| Q4 25 | $-5.7M | $-18.2M | ||
| Q3 25 | $-4.4M | $-201.0M | ||
| Q2 25 | $5.2M | $-39.7M | ||
| Q1 25 | $-17.4M | $42.6M | ||
| Q4 24 | $-3.9M | $-153.0M | ||
| Q3 24 | $-2.9M | $-14.8M | ||
| Q2 24 | $-2.9M | $-12.4M | ||
| Q1 24 | $-3.3M | $-20.8M |
| Q4 25 | — | 34.9% | ||
| Q3 25 | — | 20.7% | ||
| Q2 25 | — | 31.4% | ||
| Q1 25 | — | 30.0% | ||
| Q4 24 | — | 44.1% | ||
| Q3 24 | — | 50.6% | ||
| Q2 24 | — | 64.5% | ||
| Q1 24 | — | 49.1% |
| Q4 25 | -420.0% | -1209.7% | ||
| Q3 25 | -320.8% | -1055.4% | ||
| Q2 25 | -110.6% | -1103.9% | ||
| Q1 25 | -333.9% | -1469.6% | ||
| Q4 24 | -276.2% | -813.3% | ||
| Q3 24 | -260.9% | -729.4% | ||
| Q2 24 | -289.1% | -521.2% | ||
| Q1 24 | -196.7% | -543.4% |
| Q4 25 | -417.9% | -974.7% | ||
| Q3 25 | -316.6% | -10321.9% | ||
| Q2 25 | 370.6% | -2201.8% | ||
| Q1 25 | -1643.2% | 2895.3% | ||
| Q4 24 | -276.4% | -6726.5% | ||
| Q3 24 | -197.4% | -623.8% | ||
| Q2 24 | -229.9% | -402.5% | ||
| Q1 24 | -194.5% | -680.6% |
| Q4 25 | $0.95 | $-0.08 | ||
| Q3 25 | $-0.04 | $-0.62 | ||
| Q2 25 | $-0.01 | $-0.13 | ||
| Q1 25 | $-1.19 | $0.13 | ||
| Q4 24 | $-0.51 | $-0.80 | ||
| Q3 24 | $-0.37 | $-0.08 | ||
| Q2 24 | $-0.71 | $-0.07 | ||
| Q1 24 | $-0.75 | $-0.14 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $8.6M | $44.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $4.0M | $546.2M |
| Total Assets | $16.3M | $666.6M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $8.6M | $44.9M | ||
| Q3 25 | $16.6M | $26.1M | ||
| Q2 25 | $6.9M | $57.2M | ||
| Q1 25 | $9.9M | $37.2M | ||
| Q4 24 | $3.6M | $67.7M | ||
| Q3 24 | $4.8M | $20.3M | ||
| Q2 24 | $8.4M | $20.7M | ||
| Q1 24 | $3.2M | $35.1M |
| Q4 25 | $4.0M | $546.2M | ||
| Q3 25 | $5.1M | $371.8M | ||
| Q2 25 | $3.0M | $553.3M | ||
| Q1 25 | $-23.6M | $207.1M | ||
| Q4 24 | $-8.9M | $126.6M | ||
| Q3 24 | $-5.2M | $122.8M | ||
| Q2 24 | $-7.6M | $122.2M | ||
| Q1 24 | $-4.8M | $115.6M |
| Q4 25 | $16.3M | $666.6M | ||
| Q3 25 | $18.7M | $630.3M | ||
| Q2 25 | $10.3M | $636.7M | ||
| Q1 25 | $12.1M | $269.1M | ||
| Q4 24 | $6.6M | $284.8M | ||
| Q3 24 | $7.0M | $157.3M | ||
| Q2 24 | $11.2M | $162.4M | ||
| Q1 24 | $5.6M | $162.1M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-6.3M | $-14.9M |
| Free Cash FlowOCF − Capex | $-6.3M | $-19.5M |
| FCF MarginFCF / Revenue | -459.9% | -1042.5% |
| Capex IntensityCapex / Revenue | 2.2% | 244.8% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-20.8M | $-77.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-6.3M | $-14.9M | ||
| Q3 25 | $-2.5M | $-13.8M | ||
| Q2 25 | $-5.8M | $-16.2M | ||
| Q1 25 | $-6.2M | $-13.7M | ||
| Q4 24 | $-1.2M | $-8.5M | ||
| Q3 24 | $-3.7M | $-15.4M | ||
| Q2 24 | $-1.1M | $-13.5M | ||
| Q1 24 | $-4.5M | $-13.1M |
| Q4 25 | $-6.3M | $-19.5M | ||
| Q3 25 | $-2.6M | $-19.7M | ||
| Q2 25 | $-5.8M | $-21.8M | ||
| Q1 25 | $-6.2M | $-16.2M | ||
| Q4 24 | $-1.2M | $-9.8M | ||
| Q3 24 | $-3.7M | $-17.7M | ||
| Q2 24 | $-1.2M | $-15.6M | ||
| Q1 24 | $-4.6M | $-18.6M |
| Q4 25 | -459.9% | -1042.5% | ||
| Q3 25 | -184.3% | -1012.4% | ||
| Q2 25 | -417.6% | -1212.4% | ||
| Q1 25 | -583.1% | -1100.4% | ||
| Q4 24 | -86.5% | -432.1% | ||
| Q3 24 | -253.7% | -744.5% | ||
| Q2 24 | -96.2% | -504.3% | ||
| Q1 24 | -271.5% | -610.5% |
| Q4 25 | 2.2% | 244.8% | ||
| Q3 25 | 1.9% | 302.5% | ||
| Q2 25 | 0.5% | 314.7% | ||
| Q1 25 | 0.3% | 173.0% | ||
| Q4 24 | 0.8% | 56.4% | ||
| Q3 24 | 1.0% | 95.8% | ||
| Q2 24 | 6.3% | 66.3% | ||
| Q1 24 | 2.4% | 180.0% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -1.13× | — | ||
| Q1 25 | — | -0.32× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
PSTV
Segment breakdown not available.
RGTI
| Collaborative Research And Other Professional Services | $1.7M | 93% |
| Other | $131.0K | 7% |
